I42.7
Cardiomyopathy due to drug and external agent
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Code First
- poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
Medical Intelligence & Overview
Cardiomyopathy due to drugs and external agents, classified under ICD-10 code I42.7, is a condition where the heart muscle becomes weakened or damaged as a result of exposure to certain medications or external substances. This form of cardiomyopathy can impair the heart's ability to pump blood effectively, leading to symptoms of heart failure and other complications. Recognizing this condition is important for timely management and preventing further heart damage.
Causes & Symptoms
Clinical Causes: Use of certain prescription medications such as doxorubicin, an anthracycline used in cancer therapy Chronic excessive alcohol consumption Use of illegal drugs like cocaine and amphetamines Exposure to other toxic substances or chemicals Prolonged use of certain antibiotics or antivirals Inhalation or contact with certain environmental toxins
Key Symptoms: Shortness of breath, especially during exertion or when lying flat Fatigue and weakness Swelling in the legs, ankles, or feet Rapid or irregular heartbeat Persistent cough or wheezing Dizziness or fainting spells Chest pain or discomfort (less common)
Diagnostic & Treatment
Diagnosis Path: Review of medication and exposure history to identify potential causative agents,
Treatment Protocols: In severe cases, advanced interventions such as implantable devices or heart transplantation may be necessary.
Clinical Advice & FAQs
Billing Guidance
Is I42.7 a billable ICD-10 code?
Yes, I42.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I42.7?
Clinical documentation must specify the nature of Cardiomyopathy due to drug and external agent and any associated comorbidities for accurate reporting.
Cite this Clinical Reference